技术与方法 |
|
|
|
|
诱导回输胰岛素分泌细胞对大鼠糖尿病的疗效 |
袁凤山1, 王长军2, 董飞1, 赵宇航1 |
1. 中国医科大学附属第一医院 沈阳 110001;
2. 辽宁省铁岭市卫生局 铁岭 112000 |
|
The Therapeutic Effect of the Induced Insulin Secreting Cells on Rat Diabetes |
YUAN Feng-shan1, WANG Chang-jun2, DONG Fei1, ZHAO Yu-hang1 |
1. The First Affiliated Hospital, China Medical University, Shenyang 110001,China;
2. Health Bureau of Tieling City, Liaoning Province,Tieling 112000,China |
引用本文:
袁凤山, 王长军, 董飞, 赵宇航. 诱导回输胰岛素分泌细胞对大鼠糖尿病的疗效[J]. 中国生物工程杂志, 2011, 31(5): 94-98.
YUAN Feng-shan, WANG Chang-jun, DONG Fei, ZHAO Yu-hang. The Therapeutic Effect of the Induced Insulin Secreting Cells on Rat Diabetes. China Biotechnology, 2011, 31(5): 94-98.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2011/V31/I5/94
|
[1] Madec A M, Mallone R, Afonso G, et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia, 2009,52(7):1391-1399.
[2] 孙晓晖,王颜刚.干细胞移植定向分化为胰岛β细胞治疗糖尿病.中国组织工程研究与临床康复,2009,13(1):165-168. Sun X H, Wang Y G. Journal of Clinical Rehabilitative Tissue Engineering Research, 2009,13(1):165-168.
[3] 赵春华.干细胞原理、技术与临床应用.北京:化学工业出版社, 2006, 63-81. Zhao C H. Principle, Technology, and Clinic Application of Embryonic Cells. Beijing: Chemical Industry Press, 2006, 63-81.
[4] Choi K S, Shin J S, Lee J J, et al. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun, 2005,330(4): 1299-1305.
[5] Da Silva M L, Chagastelles P C, Nardi N B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci, 2006,119(Pt 11):2204-2213.
[6] 刘伯轩,刘师伟,王建华,等.骨髓间充质干细胞移植后2型糖尿病鼠血糖及肾脏病变的改善.中国组织工程研究与临床康复,2009,13(10):1872-1876. Liu B X, Liu S W, Wang J H, et al. Journal of Clinical Rehabilitative Tissue Engineering Research, 2009,13(10):1872-1876.
[7] Tropel P, Nale D, Platet N. Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res, 2004,295(2):395-406.
[8] Bai L, Meredith G, Tuch B E. Glucagon-like peptide-1 enhances production of insulin in insulin-producing cells derived from mouse embryonic stem cells. J Endocrinol, 2005, 186(2): 343-352.
[9] Guerci B, Martin C S. Exenatide: its position in the treatment of type 2 diabetes.Ann Endocrinol, 2008,69(3):201-209.
[10] Gao F, Wu D Q, Hu Y H, et al. In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells. Transl Res, 2008,151(6):293-302.
[11] Yu B S, Wang A R. Glucagon-like peptide 1 based therapy for type 2 diabetes. World J Pediatr, 2008,4(1): 8-13.
[12] Gao F, Wu D Q, Hu Y H, et al. In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells. Transl Res, 2008, 151(6):293-302.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|